Logo image of CPAY

CORPAY INC (CPAY) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CPAY - US2199481068 - Common Stock

310.18 USD
-1.39 (-0.45%)
Last: 12/26/2025, 7:00:00 PM
310.18 USD
0 (0%)
After Hours: 12/26/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CPAY. CPAY was compared to 99 industry peers in the Financial Services industry. CPAY has an excellent profitability rating, but there are some minor concerns on its financial health. CPAY is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CPAY had positive earnings in the past year.
In the past year CPAY had a positive cash flow from operations.
CPAY had positive earnings in each of the past 5 years.
Each year in the past 5 years CPAY had a positive operating cash flow.
CPAY Yearly Net Income VS EBIT VS OCF VS FCFCPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

CPAY has a Return On Assets of 5.32%. This is in the better half of the industry: CPAY outperforms 75.76% of its industry peers.
CPAY has a Return On Equity of 25.79%. This is amongst the best in the industry. CPAY outperforms 91.92% of its industry peers.
With an excellent Return On Invested Capital value of 10.98%, CPAY belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
CPAY had an Average Return On Invested Capital over the past 3 years of 12.51%. This is above the industry average of 8.44%.
Industry RankSector Rank
ROA 5.32%
ROE 25.79%
ROIC 10.98%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
CPAY Yearly ROA, ROE, ROICCPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 24.37%, CPAY belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Profit Margin of CPAY has declined.
CPAY has a Operating Margin of 43.73%. This is amongst the best in the industry. CPAY outperforms 80.81% of its industry peers.
CPAY's Operating Margin has been stable in the last couple of years.
CPAY has a better Gross Margin (78.26%) than 83.84% of its industry peers.
CPAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 43.73%
PM (TTM) 24.37%
GM 78.26%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
CPAY Yearly Profit, Operating, Gross MarginsCPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPAY is creating some value.
The number of shares outstanding for CPAY has been reduced compared to 1 year ago.
The number of shares outstanding for CPAY has been reduced compared to 5 years ago.
The debt/assets ratio for CPAY is higher compared to a year ago.
CPAY Yearly Shares OutstandingCPAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CPAY Yearly Total Debt VS Total AssetsCPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.15 indicates that CPAY is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CPAY (2.15) is better than 76.77% of its industry peers.
CPAY has a debt to FCF ratio of 7.10. This is a slightly negative value and a sign of low solvency as CPAY would need 7.10 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.10, CPAY is in line with its industry, outperforming 51.52% of the companies in the same industry.
CPAY has a Debt/Equity ratio of 1.86. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.86, CPAY is doing worse than 65.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.86
Debt/FCF 7.1
Altman-Z 2.15
ROIC/WACC1.41
WACC7.81%
CPAY Yearly LT Debt VS Equity VS FCFCPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.13 indicates that CPAY should not have too much problems paying its short term obligations.
CPAY's Current ratio of 1.13 is in line compared to the rest of the industry. CPAY outperforms 56.57% of its industry peers.
CPAY has a Quick Ratio of 1.13. This is a normal value and indicates that CPAY is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.13, CPAY perfoms like the industry average, outperforming 58.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
CPAY Yearly Current Assets VS Current LiabilitesCPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

7

3. Growth

3.1 Past

CPAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.43%, which is quite good.
The Earnings Per Share has been growing by 10.03% on average over the past years. This is quite good.
Looking at the last year, CPAY shows a quite strong growth in Revenue. The Revenue has grown by 11.27% in the last year.
Measured over the past years, CPAY shows a quite strong growth in Revenue. The Revenue has been growing by 8.45% on average per year.
EPS 1Y (TTM)14.43%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%14%
Revenue 1Y (TTM)11.27%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%13.92%

3.2 Future

Based on estimates for the next years, CPAY will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.01% on average per year.
CPAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.09% yearly.
EPS Next Y14.13%
EPS Next 2Y15.49%
EPS Next 3Y15.86%
EPS Next 5Y15.01%
Revenue Next Year13.12%
Revenue Next 2Y14.33%
Revenue Next 3Y13.04%
Revenue Next 5Y10.09%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CPAY Yearly Revenue VS EstimatesCPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
CPAY Yearly EPS VS EstimatesCPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

CPAY is valuated correctly with a Price/Earnings ratio of 14.98.
Compared to the rest of the industry, the Price/Earnings ratio of CPAY is on the same level as its industry peers.
CPAY is valuated rather cheaply when we compare the Price/Earnings ratio to 26.57, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.23, CPAY is valued correctly.
CPAY's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CPAY to the average of the S&P500 Index (24.04), we can say CPAY is valued slightly cheaper.
Industry RankSector Rank
PE 14.98
Fwd PE 12.23
CPAY Price Earnings VS Forward Price EarningsCPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPAY indicates a somewhat cheap valuation: CPAY is cheaper than 60.61% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CPAY is valued a bit cheaper than the industry average as 61.62% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.98
EV/EBITDA 11.6
CPAY Per share dataCPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 -60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CPAY may justify a higher PE ratio.
A more expensive valuation may be justified as CPAY's earnings are expected to grow with 15.86% in the coming years.
PEG (NY)1.06
PEG (5Y)1.49
EPS Next 2Y15.49%
EPS Next 3Y15.86%

0

5. Dividend

5.1 Amount

No dividends for CPAY!.
Industry RankSector Rank
Dividend Yield 0%

CORPAY INC

NYSE:CPAY (12/26/2025, 7:00:00 PM)

After market: 310.18 0 (0%)

310.18

-1.39 (-0.45%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners96.11%
Inst Owner Change5.9%
Ins Owners3.55%
Ins Owner Change-0.04%
Market Cap21.70B
Revenue(TTM)4.31B
Net Income(TTM)1.05B
Analysts80.91
Price Target363.28 (17.12%)
Short Float %2.21%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.37%
Min EPS beat(2)-1.79%
Max EPS beat(2)-0.95%
EPS beat(4)0
Avg EPS beat(4)-1.64%
Min EPS beat(4)-2.03%
Max EPS beat(4)-0.95%
EPS beat(8)0
Avg EPS beat(8)-1.7%
EPS beat(12)2
Avg EPS beat(12)-1.3%
EPS beat(16)5
Avg EPS beat(16)-0.41%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)-1.06%
Revenue beat(4)0
Avg Revenue beat(4)-2.27%
Min Revenue beat(4)-3.5%
Max Revenue beat(4)-1.06%
Revenue beat(8)0
Avg Revenue beat(8)-2.52%
Revenue beat(12)1
Avg Revenue beat(12)-2.1%
Revenue beat(16)4
Avg Revenue beat(16)-1.12%
PT rev (1m)-3.64%
PT rev (3m)-7.63%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)2.72%
EPS NY rev (1m)0.98%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.18%
Revenue NY rev (1m)1.48%
Revenue NY rev (3m)1.63%
Valuation
Industry RankSector Rank
PE 14.98
Fwd PE 12.23
P/S 5.03
P/FCF 18.98
P/OCF 16.24
P/B 5.32
P/tB N/A
EV/EBITDA 11.6
EPS(TTM)20.7
EY6.67%
EPS(NY)25.36
Fwd EY8.18%
FCF(TTM)16.34
FCFY5.27%
OCF(TTM)19.09
OCFY6.16%
SpS61.67
BVpS58.26
TBVpS-65.36
PEG (NY)1.06
PEG (5Y)1.49
Graham Number164.72
Profitability
Industry RankSector Rank
ROA 5.32%
ROE 25.79%
ROCE 17.42%
ROIC 10.98%
ROICexc 13.07%
ROICexgc 71.49%
OM 43.73%
PM (TTM) 24.37%
GM 78.26%
FCFM 26.5%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
ROICexc(3y)14.83%
ROICexc(5y)13.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.71%
ROCE(5y)16.98%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y1.1%
ROICexc growth 5Y0.59%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 1.86
Debt/FCF 7.1
Debt/EBITDA 3.36
Cap/Depr 52.13%
Cap/Sales 4.46%
Interest Coverage 3.9
Cash Conversion 59.22%
Profit Quality 108.76%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 2.15
F-Score6
WACC7.81%
ROIC/WACC1.41
Cap/Depr(3y)47.52%
Cap/Depr(5y)42.51%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.03%
Profit Quality(3y)145.81%
Profit Quality(5y)152.95%
High Growth Momentum
Growth
EPS 1Y (TTM)14.43%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%14%
EPS Next Y14.13%
EPS Next 2Y15.49%
EPS Next 3Y15.86%
EPS Next 5Y15.01%
Revenue 1Y (TTM)11.27%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%13.92%
Revenue Next Year13.12%
Revenue Next 2Y14.33%
Revenue Next 3Y13.04%
Revenue Next 5Y10.09%
EBIT growth 1Y9.51%
EBIT growth 3Y12.22%
EBIT growth 5Y7.35%
EBIT Next Year34.68%
EBIT Next 3Y20.62%
EBIT Next 5Y15.62%
FCF growth 1Y7.96%
FCF growth 3Y17.6%
FCF growth 5Y10.19%
OCF growth 1Y9.49%
OCF growth 3Y17.47%
OCF growth 5Y10.8%

CORPAY INC / CPAY FAQ

What is the ChartMill fundamental rating of CORPAY INC (CPAY) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CPAY.


Can you provide the valuation status for CORPAY INC?

ChartMill assigns a valuation rating of 5 / 10 to CORPAY INC (CPAY). This can be considered as Fairly Valued.


Can you provide the profitability details for CORPAY INC?

CORPAY INC (CPAY) has a profitability rating of 7 / 10.


What are the PE and PB ratios of CORPAY INC (CPAY) stock?

The Price/Earnings (PE) ratio for CORPAY INC (CPAY) is 14.98 and the Price/Book (PB) ratio is 5.32.